Evidence map›Paper›PMID 40013775›Full record

ReviewJournal of virology2025

Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns.

Anice C Lowen, Amy L Baker, Andrew S Bowman, Adolfo García-Sastre, Scott E Hensley, Seema S Lakdawala, Louise H Moncla, Martha I Nelson, Andrew Pekosz, Rebecca L Poulson and 6 more

Abstract readReview
In one paragraph

Review in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Lack of respiratory droplet transmission of two recent human influenza A(H5N1) viruses in female ferrets.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anice C LowenDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-9829-112X
Amy L BakerVirus and Prion Research Unit, National Animal Disease Center, Agricultural Research Service, U.S. Department of Pathobiology, Agriculture, Ames, Iowa, USA.ORCID 0000-0002-4953-7285
Andrew S BowmanDepartment of Veterinary Preventive Medicine, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-0738-8453
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-6551-1827
Scott E HensleyDepartment of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-2928-7506
Seema S LakdawalaDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-7679-2150
Louise H MonclaDepartment of Pathobiology, School of Veterinary Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Martha I NelsonNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Andrew PekoszW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0003-3248-1761
Rebecca L PoulsonDepartment of Population Health, University of Georgia College of Veterinary Medicine, Athens, Georgia, USA.
Wendy B PuryearDepartment of Infectious Disease & Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA.
Jonathan A RunstadlerDepartment of Infectious Disease & Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA.ORCID 0000-0002-6747-7765
Troy C SuttonDepartment of Veterinary and Biomedical Science, The Huck Institutes, The Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0000-0002-7880-4784
S Mark TompkinsCenter for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-1523-5588
Richard J WebbyDepartment of Host-Microbe Interactions, St Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-4397-7132
Risk Assessment Pipeline working group of the NIAID Centers of Excellence for Influenza Research and Response (CEIRR) Network

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00016 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBBY, RICHARD · 2021 to 2025
$91.4M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00017 · NIAID · EMORY UNIVERSITY · PI LOWEN, ANICE · 2021 to 2025
$27.3M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00045 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PEKOSZ, ANDREW · 2021 to 2025
$23.3M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00018 · NIAID · UNIVERSITY OF GEORGIA · PI TOMPKINS, S. MARK · 2021 to 2025
$21.6M
NIAID NIH HHS 75N93021C00014NIAID NIH HHS 75N93021C00015NIAID NIH HHS 75N93021C00016NIAID NIH HHS 75N93021C00017NIAID NIH HHS 75N93021C00018NIAID NIH HHS 75N93021C00045
6 · The paper itself

Abstract

H5N1 subtype influenza A viruses represent a long-standing pandemic concern. Owing to their global occurrence in poultry, humans are routinely exposed to these viruses, and hundreds of human cases have been documented worldwide since 2003. The relevant viral lineages are not static, however, and have recently undergone a massive expansion of host range and geographic distribution. Within this expansion, the introduction of H5N1 viruses into dairy cattle in the United States has spawned a novel animal-human interface. In response, public health agencies have sought to evaluate the risk of an H5N1 pandemic stemming from the bovine outbreak. These assessments draw on evidence from the field and the laboratory to score a series of recognized risk factors. As such, their utility hinges on fundamental understanding of the processes that drive pandemic emergence and the availability of relevant data. Advancing this understanding and gathering data prior to and during an outbreak are primary missions of the NIAID Centers of Excellence for Influenza Research and Response (CEIRR) Network. To further these goals and highlight the need for an invigorated response across US agencies, here, we review gaps in understanding of the dairy cattle outbreak and identify constraints on efforts to close these gaps.

Indexed as

Cattle DiseasesDisease OutbreaksInfluenza A Virus, H5N1 SubtypeInfluenza, HumanOrthomyxoviridae InfectionsPandemicsAnimalsCattleHumansRisk FactorsUnited Statesbird flubovineH5N1influenza A viruspandemic preparednessrisk assessment

Identifiers

PMID40013775
PMCPMC11998519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.